NEWS
![[Edaily] Moon-Tae Yoon, CEO Of C&R Research, Collaborates With Kakao On CDISC Clinical Standardization… ‘Crossing The FDA Threshold’](https://www.cnrres.com/wp-content/uploads/2021/04/CR-CI_홈페이지-기사-업로드용-300x200.png)
[Edaily] Moon-Tae Yoon, CEO of C&R Research, collaborates with Kakao on CDISC clinical standardization… ‘Crossing the FDA Threshold’
2024-03-08
C&R Research, a contract research organization (CRO) is undergoing a complete overhaul of its clinical data collection method. They are…
[Edaily] Moon-Tae Yoon, CEO of C&R Research, “Three Clinical Contract Orders Confirmed in the United States… Considering Establishing European Branch”
2024-02-29
Moon-Tae Yoon, CEO of C&R Research (359090), is seeing success with his overseas expansion strategy. New orders are consistently increasing…
[Edaily] C&R Research achieves 55.1 Billion KRW in Revenue Last Year… Up by 13.7% Year-on-Year
2024-02-15
C&R Research (359090) announced its provisional performance, reporting a 13.7% increase in revenue and a 41.6% increase in net profit…
[Hankyung] C&R Research and Sungkyunkwan University’s College of Pharmacy signed a clinical trial platform development agreement
2024-01-29
C&R Research announced on the 29th Jan that it has signed a joint research agreement with the College of Pharmacy at…
[Medipana] C&R Research accelerates Global Expansion in the Era of 100 Billion KRW Contract Orders
2024-01-23
C&R Research, a contract research organization (CRO) led by CEO Moon-Tae Yoon, has embarked on global market expansion with the…